CAMBRIDGE, Mass., Feb. 04, 2016 (GLOBE NEWSWIRE) -- Metabolix, Inc. (NASDAQ:MBLX), an advanced biomaterials company focused on sustainable solutions for the plastics industry, announced today that management will review 2015 highlights and discuss its outlook for 2016 in a presentation to investors at the Source Capital 2016 Disruptive Growth and Healthcare Conference in New York City on Wednesday, February 10, 2016 from 4:00 – 4:25 p.m. EST.
A live audio webcast and copy of the presentation can be accessed through the “Investors” section of the Company’s website at www.metabolix.com. Interested parties unable to listen to the live webcast can access an archived version on the Company’s website for approximately 90 days.
Metabolix, Inc. is an innovation-driven specialty materials company focused on delivering high- performance biopolymer solutions to customers in the plastics industry. Metabolix’s Mirel® biopolymers, which are derived from renewable resources, are a family of biobased performance additives and specialty resins based on PHA (polyhydroxyalkanoates). Metabolix’s proprietary biotechnology platform enables the creation of specialty biopolymers for use in a broad range of applications such as construction and packaging materials, as well as industrial, consumer and personal care products.
For more information, please visit www.metabolix.com. (MBLX-G)
Lynne H. Brum, (617) 682-4693, LBrum@metabolix.com